A Comparative Study of the Hepatoprotective Effect of Centella asiatica Extract (CA-HE50) on Lipopolysaccharide/d-galactosamine-Induced Acute Liver Injury in C57BL/6 Mice

Abstract

Acute liver failure (ALF) refers to the sudden loss of liver function and is accompanied by several complications. In a previous study, we revealed the protective effect of Centella asiatica 50% ethanol extract (CA-HE50) on acetaminophen-induced liver injury. In the present study, we investigate the hepatoprotective effect of CA-HE50 in a lipopolysaccharide/galactosamine (LPS-D-Gal)-induced ALF animal model and compare it to existing therapeutic silymarin, Lentinus edodes mycelia (LEM) extracts, ursodeoxycholic acid (UDCA) and dimethyl diphenyl bicarboxylate (DDB). Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were decreased in the CA-HE50, silymarin, LEM, UDCA and DDB groups compared to the vehicle control group. In particular, AST and ALT levels of the 200 mg/kg CA-HE50 group were significantly decreased compared to positive control groups. Lactate dehydrogenase (LDH) levels were significantly decreased in the CA-HE50, silymarin, LEM, UDCA and DDB groups compared to the vehicle control group and LDH levels of the 200 mg/kg CA-HE50 group were similar to those of the positive control groups. Superoxide dismutase (SOD) activity was significantly increased in the 100 mg/kg CA-HE50, LEM and UDCA groups compared to the vehicle control group and, in particular, the 100 mg/kg CA-HE50 group increased significantly compared to positive control groups. In addition, the histopathological lesion score was significantly decreased in the CA-HE50 and positive control groups compared with the vehicle control group and the histopathological lesion score of the 200 mg/kg CA-HE50 group was similar to that of the positive control groups. These results show that CA-HE50 has antioxidant and hepatoprotective effects at a level similar to that of silymarin, LEM, UDCA and DDB, which are known to have hepatoprotective effects; further, CA-HE50 has potential as a prophylactic and therapeutic agent in ALF.

Cold Stress Induced Liver Injury of Mice through Activated NLRP3/Caspase-1/GSDMD Pyroptosis Signaling Pathway

“…Results from our histopathological analysis demonstrated that the cells were swollen or even necrotic and disappeared, with no apparent intercellular demarcation in the cold group, and further proved cold stress-induced mouse liver pathological damages. It is well known that ALT, AST and LDH were indicators to evaluate liver function [ 30 ]. ALT is distributed in the cytoplasm, and the increase of ALT indicates that the membrane is damaged.…”

The pharmacology activities of Angelica keiskei Koidzumi and its efficacy and safety in humans

“…Chalcones contained in A. keiskei were reported for their protective activity, in term of survival growth rate, on acetaminophen-induced human hepatoma HepG2 and HeparG cells, by increasing cell growth [ 35 ]. The administration of A. keiskei juice on male obese C57BL/6J mice at dose 4 g/kg BW has reduced lipid levels in the liver (12.35 mg/g) and lipoprotein lipase mRNA expression in the gastrointestinal tract [ 14 , 52 ]. Hepatic steatosis is the amount of intrahepatic fat at least 5 % of the weight of the liver [ 53 ].…”

Medicinal herbs and their metabolites with biological potential to protect and combat liver toxicity and its disorders: A review

“…Also antiulcer, antidiabetic, cardioprotective, radioprotective, antimutagenic and skin protective. [ 83 ] Chenopodi-um album Linn. (Chenopodi-aceae) Methanolic extract of Aerial parts Wister rats Carbon tetrachloride 100,200 and 300 mg/kg p.o.…”